Search

Issue
Title
Authors
Difference of genetic polymorphisms in patients with type 2 diabetes mellitus with absence or presence of chronic heart failure with preserved ejection fraction
Sveklina T.S., Shustov S.B., Kolyubaeva S.N., Kuchmin A.N., Kozlov V.A., Halimov Y.S., Konyaev V.V.
Retrospective analysis of patients with diabetes mellitus type 2 and acute myocardial infarction
Bardymova T.P., Tsyretorova S.S., Donirova O.S.
Safety of dapagliflozin initiation in acute decompensated heart failure patients with reduced left ventricular ejection fraction
Poskakalova A.E., Nasonova S.N., Zhirov I.V., Tereshchenko S.N.
Cardiovascular outcomes of dapagliflozin in type 2 diabetes mellitus in real clinical practice: a meta-analysis of observational studies
Antsiferov M.B., Demidov N.A.
Highly selective sodium glucose cotransporter type 2 inhibitor empagliflozin neuroprotective potential in chronic brain dyscirculation
Fuks О.S., Simanenkova A.V., Timkina N.V., Tikhomirova P.A., Gagiev A.Z., Karonova T.L.
Different approaches to change gut microbiota and its influence on metabolic disorders
Shestakova E.A., Pokrovskaya E.V., Samsonova M.D.
Self-monitoring blood glucose levels and glycemic control in diabetes mellitus: medical and psychological aspects
Runova G.E.
Pharmacoeconomic aspects of the development of myocardial remodeling in patients with type 2 diabetes mellitus
Koroleva E.V., Khokhlov A.L., Sirotkina A.M.
Bariatricheskiy patsient: osnovnye aspekty podgotovki k khirurgicheskomu lecheniyu ozhireniya i vedeniya posle nego. Lektsiya dlya prakticheskikh vrachey
Ershova E.V., Komshilova K.A., Mazurina N.V., Troshina E.A.
Control of glycemia in patients with type 2 diabetes mellitus and ischemic stroke
Strongin L.G., Grigorian I.G.
Modern aspects of diabetes mellitus type 2 treatment in cardiology practice (in the context of EASD/ADA consensus and Russian guidelines)
Evdokimova A.G., Golikova A.A., Striuk R.I., Lobanova E.G.
Nonalcoholic fatty liver disease and type 2 diabetes mellitus
Rodionova S.V., Zvenigorodskaya L.A., Biryukova E.V.
Endocrinological aspects of bariatric surgery
Troshina E.A., Ershova E.V., Mazurina N.V.
Eating disorders in patients with obesity and type 2 diabetes mellitus. Lecture for physicians
Zelenkova-Zakharchuk T.A.
THE PLACE OF VITAMIN D SUPPLEMENTATION IN THE COMPLEX THERAPY OF TYPE 2 DIABETIC PATIENTS WITH DIABETIC PERIPHERAL NEUROPATHY
Stepanova A.P., Karonova T.L.
Dyslipidemia and atherosclerosis in type 2 diabetes mellitus patients. Statin therapy characteristics and comparative analysis: endocrinologist’s point of view
Demidova T.Y., Susareva O.V.
Nephroprotective properties of glucose-lowering drugs
Pokrovskaya E.V., Trubitsyna N.P., Zaytseva N.V.
Risk factors for fractures in patients with cerebrovascular disease
Shishkova V.N., Kosmatova O.V., Skripnikova I.A., Drapkina O.M.
PREDIABETES, MODERN VIEW ON RISK FACTORS AND TYPE 2 DIABETES MELLITUS PREVENTION (BASED ON “HUMAN AND MEDICATION” CONGRESS MATERIALS)
OBESITY (ESSENTIAL LABORATORY DIAGNOSTIC TESTS). GUIDELINES FOR GENERAL MEDICAL PRACTITIONERS
Troshina E.A., Komshilova K.A., Ershova E.V., Nikankina L.V., Malysheva N.M.
Diabetic nephropathy: what should cardiologist remember
Trubitsyna N.P., Zaitseva N.V., Severine A.S.
Pathogenetic substantiation inclusion of taurine in the treatment of patients with diabetes mellitus type 2
Statsenko M.E., Turkina S.V., Tyshchenko I.A., Gorbacheva E.E.
Dipeptidyl peptidase 4 inhibitors for the treatment of type 2 diabetes mellitus
Morgunova T.B., Fadeev V.V.
Diabetes mellitus and cardiovascular diseases. An updated approach to lifestyle modification and treatment of patients with diabetes mellitus type 2
Volkova E.A., Malygina O.F.
Cardiology 2020. The patient with chronic heart failure: a new trajectory of life
Motivation for improving glycemia self-monitoring efficiency in patients with diabetes mellitus: problems and solutions
Marchenkova L.A., Makarova E.V.
Polyglandular autoimmune syndrome in adults: molecular genetic and clinical characteristics (lecture)
Troshina E.A., Larina A.A., Terekhova M.A.
Pioglitazone is a forgotten hypoglycemic drug with proven cardioprotective and nephroprotective properties
Pesheva E.D., Fadeev V.V.
Pathogenetic background of dipeptidyl peptidase-4 inhibitors application in the management of diabetes mellitus type 2
Demidova T.Y., Kulenok S.G., Gasanzade P.A.
1 - 29 of 29 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies